| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |